Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Retatrutide (LY3437943) is a novel triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously
BPC-157 availability: Listed in standalone 5 mg and 10 mg vials, plus blends such as a BPC-157 and TB-500 mix, all in lyophilized powder form
For patients planning pregnancy, semaglutide should be discontinued at least 2 months before a planned pregnancy due to the long half-life, while tirzepatide may persist for approximately 1 month
Explore more blog posts from Aqua-Tox GLP-1 and Lipofirm Pro: How They Work Together How Lipofirm Pro treatments help tighten loose skin after weight loss injections RF Microneedling | Pyramid Vs Morpheus 8 How each treatment works and the differences between them Can I get Laser Hair Removal in the Summer
June 2025: A 2025 study published in JAMA Ophthalmology has found a connection between taking tirzepatide drugs like Mounjaro and developing NAION
US$ 24.98
US$ 22.91
US$ 27.30
US$ 20.75
US$ 20.22
